Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1983 Jul;24(1):137–139. doi: 10.1128/aac.24.1.137

Interferon susceptibility of herpes simplex virus strains isolated from patients enrolled in clinical trials.

J A Armstrong, M B Skicki-Mullen, M K Breinig, M Ho
PMCID: PMC185119  PMID: 6312872

Abstract

Herpes simplex virus type 1 strains isolated from patients who had received interferon in a clinical trial were not more resistant to human leukocyte interferon than strains derived from recipients of a placebo. The susceptibility of herpes simplex virus type 2 strains isolated from herpes genitalis was slightly less than that of herpes simplex virus type 1 strains causing herpes genitalis.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong J. A. Semi-micro, dye-binding assay for rabbit interferon. Appl Microbiol. 1971 Apr;21(4):723–725. doi: 10.1128/am.21.4.723-725.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Figueroa M. E., Rawls W. E. Biological markers for differentiation of herpes-virus strains of oral and genital origin. J Gen Virol. 1969 Mar;4(2):259–267. doi: 10.1099/0022-1317-4-2-259. [DOI] [PubMed] [Google Scholar]
  3. Imanishi J., Matsubara M., Kishida T., Ozaki Y., Kurimura T. Comparative studies on the inhibitory effects of interferon on various strains of herpes simplex viruses in vitro. Biken J. 1980 Sep;23(3):107–111. [PubMed] [Google Scholar]
  4. Lazar R., Breinig M. K., Armstrong J. A., Ho M. Response of cloned progeny of clinical isolates of herpes simplex virus to human leukocyte interferon. Infect Immun. 1980 Jun;28(3):708–712. doi: 10.1128/iai.28.3.708-712.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Lerner A. M., Bailey E. J. Differential sensitivity of herpes simplex virus types 1 and 2 to human interferon: antiviral effects of interferon plus 9-beta-D-arabinofuranosyladenine. J Infect Dis. 1976 Oct;134(4):400–404. doi: 10.1093/infdis/134.4.400. [DOI] [PubMed] [Google Scholar]
  6. Marks-Hellman S., Ho M. Use of biological characteristics to type Herpesvirus hominis types 1 and 2 in diagnostic laboratories. J Clin Microbiol. 1976 Mar;3(3):277–280. doi: 10.1128/jcm.3.3.277-280.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Overall J. C., Jr, Yeh T. J., Kern E. R. Sensitivity of herpes simplex virus types 1 and 2 to three preparations of human interferon. J Infect Dis. 1980 Dec;142(6):943–943. doi: 10.1093/infdis/142.6.943. [DOI] [PubMed] [Google Scholar]
  8. Pazin G. J., Armstrong J. A., Lam M. T., Tarr G. C., Jannetta P. J., Ho M. Prevention of reactivated herpes simplex infection by human leukocyte interferon after operation on the trigeminal root. N Engl J Med. 1979 Aug 2;301(5):225–230. doi: 10.1056/NEJM197908023010501. [DOI] [PubMed] [Google Scholar]
  9. Rasmussen L., Farley L. B. Inhibition of Herpesvirus hominis replication by human interferon. Infect Immun. 1975 Jul;12(1):104–108. doi: 10.1128/iai.12.1.104-108.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES